Abstract
The bone marrow (BM) hematopoietic niche is the microenvironment where in the adult hematopoietic stem and progenitor cells (HSPCs) are maintained and regulated. This regulation is tightly controlled through direct cell-cell interactions with mesenchymal stromal stem (MSCs) and reticular cells, adipocytes, osteoblasts and endothelial cells, through binding to extracellular matrix molecules and through signaling by cytokines and hematopoietic growth factors. These interactions provide a healthy environment and secure the maintenance of the HSPC pool, their proliferation, differentiation and migration. Recent studies have shown that innervation of the BM and interactions with the peripheral sympathetic neural system are important for maintenance of the hematopoietic niche, through direct interactions with HSCPs or via interactions with other cells of the HSPC microenvironment. Signaling through adrenergic receptors (ARs), opioid receptors (ORs), endocannabinoid receptors (CRs) on HSPCs and MSCs has been shown to play an important role in HSPC homeostasis and mobilization. In addition, a wide range of neuropeptides and neurotransmitters, such as Neuropeptide Y (NPY), Substance P (SP) and Tachykinins, as well as neurotrophins and neuropoietic growth factors have been shown to be involved in regulation of the hematopoietic niche. Here, a comprehensive overview is given of their role and interactions with important cells in the hematopoietic niche, including HSPCs and MSCs, and their effect on HSPC maintenance, regulation and mobilization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 2-AG:
-
2-ArachidonoylGlycerol
- ACh:
-
acetylcholine
- AEA:
-
Anandamide
- AGM:
-
aorta-gonad-mesonephros
- ARs:
-
adrenergic receptors
- BDNF:
-
Brain-Derived Growth factor
- BM:
-
bone marrow
- CBD:
-
Cannabidiol
- CD271:
-
Low affinity nerve growth factor receptor
- CFU-F:
-
Colony Forming Unit-Fibroblast
- CFU-GEMM:
-
Colony Forming Unit-Granulocyte/Erythrocyte/Monocyte/Megakaryocyte
- ChAT:
-
choline acetyltransferase
- CKs:
-
cytokines
- CNS:
-
central nervous system
- CNTF:
-
ciliary neurotrophic factor
- CRs:
-
endocannabinoid receptors
- CT-1:
-
cardiotrophin-1
- CXCL12/SDF1:
-
Stromal Derived Factor-1
- D:
-
Dopamine
- DCs:
-
Dendritic cells
- DRs:
-
dopamine receptors
- E:
-
Epinephrine/Adrenaline
- ECB:
-
Endocannabinoid
- ECM:
-
extracellular matrix
- ECs:
-
endothelial cells
- EK:
-
Endokinin
- FAAH:
-
fatty acid amide hydrolase
- FGF:
-
Fibroblasts growth factor
- FTOC:
-
fetal thymus organ cultures
- G-CSF:
-
Granulocyte-Colony Stimulating Factor
- GDNF :
-
glial cell-line derived neurotrophic factor
- GDNF:
-
Glial-derived Neurotrophic Factor
- GFLs:
-
GDNF family of ligands
- GM-CSF:
-
Granulocyte/Macrophage-Colony Stimulating Factor
- GPCRs:
-
G-protein coupled receptors
- HGFs:
-
hematopoietic growth factors
- HK-1:
-
Hemokinin-1
- HSCs:
-
hematopoietic stem cells
- HSPCs:
-
hematopoietic stem and progenitor cells
- IL:
-
Interleukin
- LIF:
-
Leukemia inhibiting factor
- LSK cells:
-
Lin−Sca+c-kit+ cells
- MIP1α:
-
Macrophage Inflammatory Protein-1alpha
- MMP:
-
Metalloproteinase
- MSCs:
-
mesenchymal stromal/stem cells
- NE:
-
Norepinephrine/Noradrenaline
- NGF:
-
Nerve growth factor
- NK cell:
-
Natural Killer cell
- NKA:
-
Neurokinin A
- NKB:
-
Neurokinin B
- NK-Rs:
-
Neurokinin receptors
- NPY:
-
Neuropeptide Y
- NTs:
-
Neurotrophins
- OBs:
-
osteoblasts
- ORs:
-
opioid receptors
- OSM:
-
Oncostatin M
- PAA:
-
periarterial adventitial cells
- PDGF:
-
Platelet-derived growth factor
- RET:
-
rearranged during transfection receptor
- RTK:
-
receptor tyrosine kinase
- SCF:
-
Stem Cell Factor
- SNS:
-
sympathetic nervous system
- SP:
-
Substance P
- TGFβ:
-
Transforming Growth Factor
- TH:
-
tyrosine hydrolase
- THC:
-
Tetrahydrocannabinol
- TK:
-
Tachykinins
- TLRs:
-
Toll-like receptors
- TNFR:
-
Tumor necrosis factor receptor
- TNFα:
-
Tumor Necrosis Factor alpha
- TPO:
-
Thrombopoietin
- Trk:
-
tropomyosin receptor kinase
- UCB:
-
Umbilical Cord Blood
- VEGF:
-
Vascular endothelial growth factor
- WT:
-
Wild type
References
Artico M, Bosco S, Cavallotti C, Agostinelli E, Giuliani-Piccari G, Sciorio S, Cocco L, Vitale M (2002) Noradrenergic and cholinergic innervation of the bone marrow. Int J Mol Med 10(1):77–80
Auffray I, Chevalier S, Froger J, Izac B, Vainchenker W, Gascan H, Coulombel L (1996) Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. Blood 88(5):1608–1618
Aydin G (2018) Detailed characterization of MSCs from different sources, their ability to support lymphohematopoiesis and the importance of CD271 antigen for their isolation. Hacettepe University, Ankara
Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109(7):915–921. https://doi.org/10.1172/JCI14588
Baldock PA, Lee NJ, Driessler F, Lin S, Allison S, Stehrer B, Lin EJ, Zhang L, Enriquez RF, Wong IP, McDonald MM, During M, Pierroz DD, Slack K, Shi YC, Yulyaningsih E, Aljanova A, Little DG, Ferrari SL, Sainsbury A, Eisman JA, Herzog H (2009) Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One 4(12):e8415. https://doi.org/10.1371/journal.pone.0008415
Bandari PS, Qian J, Oh HS, Potian JA, Yehia G, Harrison JS, Rameshwar P (2003) Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter. J Neuroimmunol 138(1–2):65–75
Beaujouan JC, Torrens Y, Saffroy M, Kemel ML, Glowinski J (2004) A 25 year adventure in the field of tachykinins. Peptides 25(3):339–357. https://doi.org/10.1016/j.peptides.2004.02.011
Benard A, Boue J, Chapey E, Jaume M, Gomes B, Dietrich G (2008) Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells. J Neuroimmunol 197(1):21–28. https://doi.org/10.1016/j.jneuroim.2008.03.020
Benarroch EE (2012) Endogenous opioid systems: current concepts and clinical correlations. Neurology 79(8):807–814. https://doi.org/10.1212/WNL.0b013e3182662098
Berger A, Frelin C, Shah DK, Benveniste P, Herrington R, Gerard NP, Zuniga-Pflucker JC, Iscove NN, Paige CJ (2013) Neurokinin-1 receptor signalling impacts bone marrow repopulation efficiency. PLoS One 8(3):e58787. https://doi.org/10.1371/journal.pone.0058787
Bidlack JM (2000) Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 7(5):719–723. https://doi.org/10.1128/cdli.7.5.719-723.2000
Boranic M, Krizanac-Bengez L, Gabrilovac J, Marotti T, Breljak D (1997) Enkephalins in hematopoiesis. Biomed Pharmacother 51(1):29–37
Bothwell M (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18:223–253. https://doi.org/10.1146/annurev.ne.18.030195.001255
Bracci-Laudiero L, Celestino D, Starace G, Antonelli A, Lambiase A, Procoli A, Rumi C, Lai M, Picardi A, Ballatore G, Bonini S, Aloe L (2003) CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J Neuroimmunol 136(1–2):130–139
Brothers SP, Wahlestedt C (2010) Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol Med 2(11):429–439. https://doi.org/10.1002/emmm.201000100
Bruckner K (2011) Blood cells need glia, too: a new role for the nervous system in the bone marrow niche. Cell Stem Cell 9(6):493–495. https://doi.org/10.1016/j.stem.2011.11.016
Burbach JP (2010) Neuropeptides from concept to online database www.neuropeptides.nl. Eur J Pharmacol 626(1):27–48. https://doi.org/10.1016/j.ejphar.2009.10.015
Burbach JPH (2011) Chapter 1: What are neuropeptides? In: Merighi A (ed). https://doi.org/10.1007/978-1-61779-310-3
Calvo W, Forteza-Vila J (1969) On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy. Am J Anat 126(3):355–371. https://doi.org/10.1002/aja.1001260308
Caneva L, Soligo D, Cattoretti G, De Harven E, Deliliers GL (1995) Immuno-electron microscopy characterization of human bone marrow stromal cells with anti-NGFR antibodies. Blood Cells Mol Dis 21(2):73–85
Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo MP (1993) Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 81(7):1726–1738
Chesa PG, Rettig WJ, Thomson TM, Old LJ, Melamed MR (1988) Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem 36(4):383–389. https://doi.org/10.1177/36.4.2831267
Cosentino M, Marino F, Maestroni GJ (2015) Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives. Front Cell Neurosci 9:302. https://doi.org/10.3389/fncel.2015.00302
Cox G, Boxall SA, Giannoudis PV, Buckley CT, Roshdy T, Churchman SM, McGonagle D, Jones E (2012) High abundance of CD271(+) multipotential stromal cells (MSCs) in intramedullary cavities of long bones. Bone 50(2):510–517. https://doi.org/10.1016/j.bone.2011.07.016
Diaz-Laviada I, Ruiz-Llorente L (2005) Signal transduction activated by cannabinoid receptors. Mini Rev Med Chem 5(7):619–630
Felten SY, Felten DL, Bellinger DL, Olschowka JA (1992) Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 52:25–48
Fitch SR, Kimber GM, Wilson NK, Parker A, Mirshekar-Syahkal B, Gottgens B, Medvinsky A, Dzierzak E, Ottersbach K (2012) Signaling from the sympathetic nervous system regulates hematopoietic stem cell emergence during embryogenesis. Cell Stem Cell 11(4):554–566. https://doi.org/10.1016/j.stem.2012.07.002
Fonseca-Pereira D, Arroz-Madeira S, Rodrigues-Campos M, Barbosa IA, Domingues RG, Bento T, Almeida AR, Ribeiro H, Potocnik AJ, Enomoto H, Veiga-Fernandes H (2014) The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function. Nature 514(7520):98–101. https://doi.org/10.1038/nature13498
Garcia-Garcia A, Korn C, Garcia-Fernandez M, Domingues O, Villadiego J, Martin-Perez D, Isern J, Bejarano-Garcia JA, Zimmer J, Perez-Simon JA, Toledo-Aral JJ, Michel T, Airaksinen MS, Mendez-Ferrer S (2019) Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes. Blood 133(3):224–236. https://doi.org/10.1182/blood-2018-08-867648
Gerard NP, Bao L, Xiao-Ping H, Gerard C (1993) Molecular aspects of the tachykinin receptors. Regul Pept 43(1–2):21–35
Gol’dberg ED, Zakharova O, Dygai AM, Simanina EV, Agafonov VI (1987) Modulating effect of enkephalins on hemopoieis under stress. Biull Eksp Biol Med 103(5):589–590
Gowran A, McKayed K, Campbell VA (2013) The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health. Stem Cells Int 2013:796715. https://doi.org/10.1155/2013/796715
Greco SJ, Corcoran KE, Cho KJ, Rameshwar P (2004) Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci 9:1782–1793
Han D, Li X, Fan WS, Chen JW, Gou TT, Su T, Fan MM, Xu MQ, Wang YB, Ma S, Qiu Y, Cao F (2017) Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation. Oncotarget 8(39):64853–64866. https://doi.org/10.18632/oncotarget.17614
Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV (1991) High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350(6320):678–683. https://doi.org/10.1038/350678a0
Herzog H, Hort YJ, Shine J, Selbie LA (1993) Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation. DNA Cell Biol 12(6):465–471. https://doi.org/10.1089/dna.1993.12.465
Higuchi S, Ii M, Zhu P, Ashraf M (2012) Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway. Circ J 76(1):204–212
Hirabayashi A, Nishiwaki K, Taki K, Shimada Y, Ishikawa N (1994) Effects of neuropeptide Y on lung vascular permeability in the pulmonary circulation of rats. Eur J Pharmacol 256(2):227–230
Holzer P (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24(3):739–768
Idris AI, van ’t Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH (2005) Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 11(7):774–779. https://doi.org/10.1038/nm1255
Idris AI, Sophocleous A, Landao-Bassonga E, van’t Hof RJ, Ralston SH (2008) Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology 149(11):5619–5626. https://doi.org/10.1210/en.2008-0150
Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, Baker D, van’t Hof RJ, Ralston SH (2009) Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab 10(2):139–147. https://doi.org/10.1016/j.cmet.2009.07.006
Igura K, Haider H, Ahmed RP, Sheriff S, Ashraf M (2011) Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells. Rejuvenation Res 14(4):393–403. https://doi.org/10.1089/rej.2010.1129
Ip NY (1998) The neurotrophins and neuropoietic cytokines: two families of growth factors acting on neural and hematopoietic cells. Ann N Y Acad Sci 840:97–106
Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, Greene LA, Barbacid M, Yancopoulos GD (1993) Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 10(2):137–149
Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, Groopman JE, Avraham HK (2011a) Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 117(3):827–838. https://doi.org/10.1182/blood-2010-01-265082
Jiang S, Fu Y, Avraham HK (2011b) Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system. Transfusion 51(Suppl 4):65S–71S. https://doi.org/10.1111/j.1537-2995.2011.03368.x
Jones E, English A, Churchman SM, Kouroupis D, Boxall SA, Kinsey S, Giannoudis PG, Emery P, McGonagle D (2010) Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum 62(7):1944–1954. https://doi.org/10.1002/art.27451
Jorda MA, Verbakel SE, Valk PJ, Vankan-Berkhoudt YV, Maccarrone M, Finazzi-Agro A, Lowenberg B, Delwel R (2002) Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99(8):2786–2793
Joshi DD, Dang A, Yadav P, Qian J, Bandari PS, Chen K, Donnelly R, Castro T, Gascon P, Haider A, Rameshwar P (2001) Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study. Blood 98(9):2697–2706
Jung WC, Levesque JP, Ruitenberg MJ (2017) It takes nerve to fight back: The significance of neural innervation of the bone marrow and spleen for immune function. Semin Cell Dev Biol 61:60–70. https://doi.org/10.1016/j.semcdb.2016.08.010
Kalinkovich A, Spiegel A, Shivtiel S, Kollet O, Jordaney N, Piacibello W, Lapidot T (2009) Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav Immun 23(8):1059–1065. https://doi.org/10.1016/j.bbi.2009.03.008
Kang HS, Trzaska KA, Corcoran K, Chang VT, Rameshwar P (2004) Neurokinin receptors: relevance to the emerging immune system. Arch Immunol Ther Exp 52(5):338–347
Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124(2):407–421. https://doi.org/10.1016/j.cell.2005.10.041
Kieffer BL, Evans CJ (2009) Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 56(Suppl 1):205–212. https://doi.org/10.1016/j.neuropharm.2008.07.033
Klassert TE, Pinto F, Hernandez M, Candenas ML, Hernandez MC, Abreu J, Almeida TA (2008) Differential expression of neurokinin B and hemokinin-1 in human immune cells. J Neuroimmunol 196(1–2):27–34. https://doi.org/10.1016/j.jneuroim.2008.02.010
Klassert TE, Patel SA, Rameshwar P (2010) Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link. J Receptor Ligand Channel Res 2010(3):51–61
Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA (2015) Circulating endocannabinoids during hematopoietic stem cell transplantation: a pilot study. Neurobiol Stress 2:44–50. https://doi.org/10.1016/j.ynstr.2015.05.001
Kose S, Aerts-Kaya F, Kopru CZ, Nemutlu E, Kuskonmaz B, Karaosmanoglu B, Taskiran EZ, Altun B, Uckan Cetinkaya D, Korkusuz P (2018) Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation. Exp Hematol 57:30–41 e31. https://doi.org/10.1016/j.exphem.2017.09.009
Krizanac-Bengez LJ, Breljak D, Boranic M (1996) Suppressive effect of met-enkephalin on bone marrow cell proliferation in vitro shows circadian pattern and depends on the presence of adherent accessory cells. Biomed Pharmacother 50(2):85–91
Kuci S, Kuci Z, Kreyenberg H, Deak E, Putsch K, Huenecke S, Amara C, Koller S, Rettinger E, Grez M, Koehl U, Latifi-Pupovci H, Henschler R, Tonn T, von Laer D, Klingebiel T, Bader P (2010) CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica 95(4):651–659. https://doi.org/10.3324/haematol.2009.015065
Kulkarni-Narla A, Walcheck B, Brown DR (2001) Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression. Eur J Pharmacol 414(2–3):289–294
Kuntz A, Richins CA (1945) Innervation of the bone marrow. J Comp Neurol 83:213–222
Kuo LE, Abe K, Zukowska Z (2007) Stress, NPY and vascular remodeling: Implications for stress-related diseases. Peptides 28(2):435–440. https://doi.org/10.1016/j.peptides.2006.08.035
Lapidot T, Kollet O (2010) The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. Hematology Am Soc Hematol Educ Program 2010:1–6. https://doi.org/10.1182/asheducation-2010.1.1
Lee NJ, Herzog H (2009) NPY regulation of bone remodelling. Neuropeptides 43(6):457–463. https://doi.org/10.1016/j.npep.2009.08.006
Lee NJ, Doyle KL, Sainsbury A, Enriquez RF, Hort YJ, Riepler SJ, Baldock PA, Herzog H (2010) Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res 25(8):1736–1747. https://doi.org/10.1002/jbmr.61
Levi-Montalcini R, Angeletti PU (1963) Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol 6:653–659
Lin S, Boey D, Herzog H (2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38(4):189–200. https://doi.org/10.1016/j.npep.2004.05.005
Liu K, Castillo MD, Murthy RG, Patel N, Rameshwar P (2007) Tachykinins and hematopoiesis. Clin Chim Acta 385(1–2):28–34. https://doi.org/10.1016/j.cca.2007.07.008
Liu S, Jin D, Wu JQ, Xu ZY, Fu S, Mei G, Zou ZL, Ma SH (2016) Neuropeptide Y stimulates osteoblastic differentiation and VEGF expression of bone marrow mesenchymal stem cells related to canonical Wnt signaling activating in vitro. Neuropeptides 56:105–113. https://doi.org/10.1016/j.npep.2015.12.008
Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6(8):603–614. https://doi.org/10.1038/nrn1726
Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS (2013) Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat Med 19(6):695–703. https://doi.org/10.1038/nm.3155
Luder E, Ramer R, Peters K, Hinz B (2017) Decisive role of P42/44 mitogen-activated protein kinase in Delta(9)-tetrahydrocannabinol-induced migration of human mesenchymal stem cells. Oncotarget 8(62):105984–105994. https://doi.org/10.18632/oncotarget.22517
Lundberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, Rost S, Enriquez RF, Sainsbury A, Lamghari M, Simmons P, Eisman JA, Gardiner EM, Herzog H (2007) Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 282(26):19082–19091. https://doi.org/10.1074/jbc.M609629200
Maccarrone M, Bab I, Biro T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A (2015) Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci 36(5):277–296. https://doi.org/10.1016/j.tips.2015.02.008
Maestroni GJ (1998) kappa-Opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin-induced opioid cytokines. Ann N Y Acad Sci 840:411–419
Maestroni GJ, Conti A (1994) Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells. Exp Hematol 22(3):313–320
Maestroni GJ, Conti A, Pedrinis E (1992) Effect of adrenergic agents on hematopoiesis after syngeneic bone marrow transplantation in mice. Blood 80(5):1178–1182
Maestroni GJ, Zammaretti F, Pedrinis E (1999) Hematopoietic effect of melatonin involvement of type 1 kappa-opioid receptor on bone marrow macrophages and interleukin-1. J Pineal Res 27(3):145–153
Marino F, Cosentino M, Bombelli R, Ferrari M, Maestroni GJ, Conti A, Lecchini S, Frigo G (1997) Measurement of catecholamines in mouse bone marrow by means of HPLC with electrochemical detection. Haematologica 82(4):392–394
Matsuda H, Coughlin MD, Bienenstock J, Denburg JA (1988) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci U S A 85(17):6508–6512. https://doi.org/10.1073/pnas.85.17.6508
McAllister AK (2001) Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci 58(8):1054–1060. https://doi.org/10.1007/PL00000920
Mendez-Ferrer S, Lucas D, Battista M, Frenette PS (2008) Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452(7186):442–447. https://doi.org/10.1038/nature06685
Mendez-Ferrer S, Battista M, Frenette PS (2010) Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization. Ann N Y Acad Sci 1192:139–144. https://doi.org/10.1111/j.1749-6632.2010.05390.x
Mo FM, Offertaler L, Kunos G (2004) Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur J Pharmacol 489(1–2):21–27. https://doi.org/10.1016/j.ejphar.2004.02.034
Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature 505(7483):327–334. https://doi.org/10.1038/nature12984
Morteau O, Lu B, Gerard C, Gerard NP (2001) Hemokinin 1 is a full agonist at the substance P receptor. Nat Immunol 2(12):1088. https://doi.org/10.1038/ni1201-1088
Muthu K, Iyer S, He LK, Szilagyi A, Gamelli RL, Shankar R, Jones SB (2007) Murine hematopoietic stem cells and progenitors express adrenergic receptors. J Neuroimmunol 186(1–2):27–36. https://doi.org/10.1016/j.jneuroim.2007.02.007
Nan YS, Feng GG, Hotta Y, Nishiwaki K, Shimada Y, Ishikawa A, Kurimoto N, Shigei T, Ishikawa N (2004) Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer. Am J Physiol Heart Circ Physiol 286(3):H1027–H1033. https://doi.org/10.1152/ajpheart.00630.2003
Nowicki M, Miskowiak B (2003) Substance P–a potent risk factor in childhood lymphoblastic leukaemia. Leukemia 17(6):1096–1099. https://doi.org/10.1038/sj.leu.2402920
Nowicki M, Miskowiak B, Ostalska-Nowicka D (2003) Detection of substance P and its mRNA in human blast cells in childhood lymphoblastic leukaemia using immunocytochemistry and in situ hybridisation. Folia Histochem Cytobiol 41(1):33–36
Nowicki M, Ostalska-Nowicka D, Kondraciuk B, Miskowiak B (2007) The significance of substance P in physiological and malignant haematopoiesis. J Clin Pathol 60(7):749–755. https://doi.org/10.1136/jcp.2006.041475
Nykjaer A, Willnow TE, Petersen CM (2005) p75NTR--live or let die. Curr Opin Neurobiol 15(1):49–57. https://doi.org/10.1016/j.conb.2005.01.004
Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 103(3):696–701. https://doi.org/10.1073/pnas.0504187103
Park MH, Jin HK, Min WK, Lee WW, Lee JE, Akiyama H, Herzog H, Enikolopov GN, Schuchman EH, Bae JS (2015a) Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow. EMBO J 34(12):1648–1660. https://doi.org/10.15252/embj.201490174
Park MH, Min WK, Jin HK, Bae JS (2015b) Role of neuropeptide Y in the bone marrow hematopoietic stem cell microenvironment. BMB Rep 48(12):645–646
Park MH, Lee JK, Kim N, Min WK, Lee JE, Kim KT, Akiyama H, Herzog H, Schuchman EH, Jin HK, Bae JS (2016) Neuropeptide Y Induces Hematopoietic Stem/Progenitor Cell Mobilization by Regulating Matrix Metalloproteinase-9 Activity Through Y1 Receptor in Osteoblasts. Stem Cells 34(8):2145–2156. https://doi.org/10.1002/stem.2383
Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R (2008) Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Eur J Pharmacol 595(1–3):1–6. https://doi.org/10.1016/j.ejphar.2008.05.002
Pelletier L, Angonin R, Regnard J, Fellmann D, Charbord P (2002) Human bone marrow angiogenesis: in vitro modulation by substance P and neurokinin A. Br J Haematol 119(4):1083–1089
Peng S, Zhou YL, Song ZY, Lin S (2017) Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy. Stem Cells Int 2017:6823917. https://doi.org/10.1155/2017/6823917
Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA (2004) Tachykinins and tachykinin receptors: a growing family. Life Sci 74(12):1445–1463
Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3(7):687–694. https://doi.org/10.1038/ni813
Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30(7):783–791
Rameshwar P, Gascon P (1995) Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86(2):482–490
Rameshwar P, Gascon P (1996) Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 88(1):98–106
Rameshwar P, Ganea D, Gascon P (1993a) In vitro stimulatory effect of substance P on hematopoiesis. Blood 81(2):391–398
Rameshwar P, Gascon P, Ganea D (1993b) Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol 151(5):2484–2496
Rameshwar P, Poddar A, Gascon P (1997) Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymphoma 28(1–2):1–10. https://doi.org/10.3109/10428199709058325
Rezaee F, Rellick SL, Piedimonte G, Akers SM, O’Leary HA, Martin K, Craig MD, Gibson LF (2010) Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One 5(3):e9690. https://doi.org/10.1371/journal.pone.0009690
Rogers ML, Beare A, Zola H, Rush RA (2008) CD 271 (P75 neurotrophin receptor). J Biol Regul Homeost Agents 22(1):1–6
Rossi F, Bernardo ME, Bellini G, Luongo L, Conforti A, Manzo I, Guida F, Cristino L, Imperatore R, Petrosino S, Nobili B, Di Marzo V, Locatelli F, Maione S (2013) The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. PLoS One 8(11):e80022. https://doi.org/10.1371/journal.pone.0080022
Rozenfeld-Granot G, Toren A, Amariglio N, Nagler A, Rosenthal E, Biniaminov M, Brok-Simoni F, Rechavi G (2002) MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(−) cells. Exp Hematol 30(5):473–480
Ruhl T, Kim BS, Beier JP (2018) Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells. Exp Cell Res 370(2):653–662. https://doi.org/10.1016/j.yexcr.2018.07.030
Satoh M, Minami M (1995) Molecular pharmacology of the opioid receptors. Pharmacol Ther 68(3):343–364
Schmuhl E, Ramer R, Salamon A, Peters K, Hinz B (2014) Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK. Biochem Pharmacol 87(3):489–501. https://doi.org/10.1016/j.bcp.2013.11.016
Scutt A, Williamson EM (2007) Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcif Tissue Int 80(1):50–59. https://doi.org/10.1007/s00223-006-0171-7
Shahrokhi S, Ebtekar M, Alimoghaddam K, Sharifi Z, Ghaffari SH, Pourfathollah AA, Kheirandish M, Mohseni M, Ghavamzadeh A (2010) Communication of substance P, calcitonin-gene-related neuropeptides and chemokine receptor 4 (CXCR4) in cord blood hematopoietic stem cells. Neuropeptides 44(5):385–389. https://doi.org/10.1016/j.npep.2010.06.002
Sharp BM, Roy S, Bidlack JM (1998) Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol 83(1–2):45–56
Simone MD, De Santis S, Vigneti E, Papa G, Amadori S, Aloe L (1999) Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 17(1):1–10
Singh P, Hoggatt J, Kamocka MM, Mohammad KS, Saunders MR, Li H, Speth J, Carlesso N, Guise TA, Pelus LM (2017) Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. J Clin Invest 127(12):4527–4540. https://doi.org/10.1172/JCI94687
Smith M, Wilson R, O’Brien S, Tufarelli C, Anderson SI, O’Sullivan SE (2015) The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation. PLoS One 10(9):e0136546. https://doi.org/10.1371/journal.pone.0136546
Sousa DM, Herzog H, Lamghari M (2009) NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Curr Drug Targets 10(1):9–19
Sousa DM, Baldock PA, Enriquez RF, Zhang L, Sainsbury A, Lamghari M, Herzog H (2012) Neuropeptide Y Y1 receptor antagonism increases bone mass in mice. Bone 51(1):8–16. https://doi.org/10.1016/j.bone.2012.03.020
Spiegel A, Shivtiel S, Kalinkovich A, Ludin A, Netzer N, Goichberg P, Azaria Y, Resnick I, Hardan I, Ben-Hur H, Nagler A, Rubinstein M, Lapidot T (2007) Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 8(10):1123–1131. https://doi.org/10.1038/ni1509
Stead RH, Bienenstock J, Stanisz AM (1987) Neuropeptide regulation of mucosal immunity. Immunol Rev 100:333–359
Steidl U, Bork S, Schaub S, Selbach O, Seres J, Aivado M, Schroeder T, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Bornstein SR, Haas HL, Kobbe G, Tenen DG, Haas R, Kronenwett R (2004) Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood 104(1):81–88. https://doi.org/10.1182/blood-2004-01-0373
Tabarowski Z, Gibson-Berry K, Felten SY (1996) Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem 98(4):453–457. https://doi.org/10.1016/S0065-1281(96)80013-4
Taga T (1996) Gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J Neurochem 67(1):1–10
Teixeira L, Sousa DM, Nunes AF, Sousa MM, Herzog H, Lamghari M (2009) NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. J Cell Biochem 107(5):908–916. https://doi.org/10.1002/jcb.22194
Tian M, Broxmeyer HE, Fan Y, Lai Z, Zhang S, Aronica S, Cooper S, Bigsby RM, Steinmetz R, Engle SJ, Mestek A, Pollock JD, Lehman MN, Jansen HT, Ying M, Stambrook PJ, Tischfield JA, Yu L (1997) Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J Exp Med 185(8):1517–1522. https://doi.org/10.1084/jem.185.8.1517
Tsuda T, Wong D, Dolovich J, Bienenstock J, Marshall J, Denburg JA (1991) Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 77(5):971–979
Ulum B (2019) Assessment of the role of Neuropeptide Y in the regulation of hematopoietic stem cells. Middle East Technical University, Ankara
Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Lowenberg B, Delwel R (1997) Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90(4):1448–1457
Waldhoer M, Bartlett SE, Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953–990. https://doi.org/10.1146/annurev.biochem.73.011303.073940
Wang Y, Zhang D, Ashraf M, Zhao T, Huang W, Ashraf A, Balasubramaniam A (2010) Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 298(1):H275–H286. https://doi.org/10.1152/ajpheart.00765.2009
Wang L, Yang L, Tian L, Mai P, Jia S, Yang L, Li L (2017) Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury. J Cell Physiol 232(1):110–121. https://doi.org/10.1002/jcp.25395
Wee NKY, Sinder BP, Novak S, Wang X, Stoddard C, Matthews BG, Kalajzic I (2019) Skeletal phenotype of the neuropeptide Y knockout mouse. Neuropeptides 73:78–88. https://doi.org/10.1016/j.npep.2018.11.009
Wheway J, Mackay CR, Newton RA, Sainsbury A, Boey D, Herzog H, Mackay F (2005) A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202(11):1527–1538. https://doi.org/10.1084/jem.20051971
Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ, Ross RA, Rogers MJ (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106(38):16511–16516. https://doi.org/10.1073/pnas.0902743106
Wollank Y, Ramer R, Ivanov I, Salamon A, Peters K, Hinz B (2015) Inhibition of FAAH confers increased stem cell migration via PPARalpha. J Lipid Res 56(10):1947–1960. https://doi.org/10.1194/jlr.M061473
Wu J, Liu S, Meng H, Qu T, Fu S, Wang Z, Yang J, Jin D, Yu B (2017) Neuropeptide Y enhances proliferation and prevents apoptosis in rat bone marrow stromal cells in association with activation of the Wnt/beta-catenin pathway in vitro. Stem Cell Res 21:74–84. https://doi.org/10.1016/j.scr.2017.04.001
Xie J, Xiao D, Xu Y, Zhao J, Jiang L, Hu X, Zhang Y, Yu L (2016) Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. Oncotarget 7(6):6436–6447. https://doi.org/10.18632/oncotarget.7042
Yamaguchi M, Levy RM (2016) beta-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro. Exp Ther Med 12(6):3602–3606. https://doi.org/10.3892/etm.2016.3818
Yamazaki K, Allen TD (1990) Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the “neuro-reticular complex”. Am J Anat 187(3):261–276. https://doi.org/10.1002/aja.1001870306
Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, Taketo MM, Karlsson S, Iwama A, Nakauchi H (2011) Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147(5):1146–1158. https://doi.org/10.1016/j.cell.2011.09.053
Zhang Y, Paige CJ (2003) T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 102(6):2165–2172. https://doi.org/10.1182/blood-2002-11-3572
Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ (2000) Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 1(5):392–397. https://doi.org/10.1038/80826
Acknowledgements
This manuscript was supported by grants from the Scientific and Technological Research Council of Turkey, project no 318S073 and the Hacettepe University, Scientific Research Project Coordination Unit TYL-2018-17435 and THD-2018-17209.
Conflicts of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Aerts-Kaya, F. et al. (2019). Neurological Regulation of the Bone Marrow Niche. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 6. Advances in Experimental Medicine and Biology(), vol 1212. Springer, Cham. https://doi.org/10.1007/5584_2019_398
Download citation
DOI: https://doi.org/10.1007/5584_2019_398
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-32822-1
Online ISBN: 978-3-030-32823-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)